Submitted by pgmccaffrey_246321 on Mon, 06/28/2021 - 2:50pm NCT04623242 Solanezumab Gantenerumab United States Friday, December 28, 2012 – Friday, March 6, 2020 194 Phase 2/3 Familial Alzheimer's Disease Monday, June 28, 2021 Washington University School of Medicine Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by pgmccaffrey_246321 on
Submitted by pgmccaffrey_246321 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.